252 related articles for article (PubMed ID: 32858135)
1. Construction and validation of a TP53-associated immune prognostic model for gastric cancer.
Nie K; Zheng Z; Wen Y; Shi L; Xu S; Wang X; Zhou Y; Fu B; Li X; Deng Z; Pan J; Jiang X; Jiang K; Yan Y; Zhuang K; Huang W; Liu F; Li P
Genomics; 2020 Nov; 112(6):4788-4795. PubMed ID: 32858135
[TBL] [Abstract][Full Text] [Related]
2. Eleven immune-gene pairs signature associated with TP53 predicting the overall survival of gastric cancer: a retrospective analysis of large sample and multicenter from public database.
Huo J; Wu L; Zang Y
J Transl Med; 2021 Apr; 19(1):183. PubMed ID: 33926488
[TBL] [Abstract][Full Text] [Related]
3. Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinoma.
Wu C; Rao X; Lin W
Cancer Med; 2021 Feb; 10(3):806-823. PubMed ID: 33314730
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma.
Long J; Wang A; Bai Y; Lin J; Yang X; Wang D; Yang X; Jiang Y; Zhao H
EBioMedicine; 2019 Apr; 42():363-374. PubMed ID: 30885723
[TBL] [Abstract][Full Text] [Related]
5. SnapShot: TP53 status and macrophages infiltration in TCGA-analyzed tumors.
El-Arabey AA; Abdalla M; Abd-Allah AR
Int Immunopharmacol; 2020 Sep; 86():106758. PubMed ID: 32663767
[TBL] [Abstract][Full Text] [Related]
6. A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer.
Wu X; Lv D; Cai C; Zhao Z; Wang M; Chen W; Liu Y
Front Immunol; 2020; 11():590618. PubMed ID: 33391264
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of tumor mutation burden and immune microenvironment in gastric cancer.
Yu J; Zhang Q; Wang M; Liang S; Huang H; Xie L; Cui C; Yu J
Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33492335
[TBL] [Abstract][Full Text] [Related]
8. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
[TBL] [Abstract][Full Text] [Related]
9. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z
Front Immunol; 2021; 12():685992. PubMed ID: 34262565
[TBL] [Abstract][Full Text] [Related]
10. Establishment and validation of an immune-based prognostic score model in glioblastoma.
Qin Z; Zhang X; Chen Z; Liu N
Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
[TBL] [Abstract][Full Text] [Related]
12. A
Xu F; Lin H; He P; He L; Chen J; Lin L; Chen Y
Oncoimmunology; 2020; 9(1):1731943. PubMed ID: 32158625
[TBL] [Abstract][Full Text] [Related]
13. Potential Predictive Value of
Dong ZY; Zhong WZ; Zhang XC; Su J; Xie Z; Liu SY; Tu HY; Chen HJ; Sun YL; Zhou Q; Yang JJ; Yang XN; Lin JX; Yan HH; Zhai HR; Yan LX; Liao RQ; Wu SP; Wu YL
Clin Cancer Res; 2017 Jun; 23(12):3012-3024. PubMed ID: 28039262
[No Abstract] [Full Text] [Related]
14. Clinical significance and prognostic role of an immune-related gene signature in gastric adenocarcinoma.
Mao R; Liu K; Zhao N; Guo P; Wu Y; Wang Z; Liu Y; Zhang T
Aging (Albany NY); 2021 Jul; 13(13):17734-17767. PubMed ID: 34247148
[TBL] [Abstract][Full Text] [Related]
15. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
16. A novel tp53-associated nomogram to predict the overall survival in patients with pancreatic cancer.
Liu X; Chen B; Chen J; Sun S
BMC Cancer; 2021 Mar; 21(1):335. PubMed ID: 33789615
[TBL] [Abstract][Full Text] [Related]
17. Tumor Immunophenotyping-Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer.
Wang JB; Qiu QZ; Zheng QL; Zhao YJ; Xu Y; Zhang T; Wang SH; Wang Q; Jin QW; Ye YH; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Yang YH; Zheng CH; Huang CM
Adv Sci (Weinh); 2023 May; 10(15):e2207417. PubMed ID: 36998102
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of CLEC11A and its derived immune signature in gastric cancer.
Zheng Q; Gong Z; Li B; Cheng R; Luo W; Huang C; Wang H
Front Immunol; 2024; 15():1324959. PubMed ID: 38348052
[TBL] [Abstract][Full Text] [Related]
19. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
Ren N; Liang B; Li Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
